FDMT financials
4D Molecular (FDMT) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
FDMT income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $85.21M | $77.58M | -$159.55M | -$140.11M | -2.42 |
| 2024 | $37.00K | -$141.26M | -$187.84M | -$160.87M | -2.98 |
| 2023 | $20.72M | -$76.37M | -$112.87M | -$100.84M | -2.58 |
| 2022 | $3.13M | -$77.12M | -$110.03M | -$107.49M | -3.12 |
| 2021 | $18.04M | -$43.32M | -$71.33M | -$71.32M | -2.46 |
| 2020 | $13.61M | -$39.43M | -$56.66M | -$56.69M | -2.12 |
- FDMT revenue was $85.21M in fiscal 2025, net income -$140.11M.
Updated 2026-11-07 11:54 UTC